Behavioral aspects and neurobiological properties underlying medical cannabis treatment in Shank3 mouse model of autism spectrum disorder

Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-α, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL J mice

Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms - a real-life report of multi-symptomatic benefits

A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy a case report

Cannabidiol in Treatment of Autism Spectrum Disorder A Case Study